Profile of brivaracetam and its potential in the treatment of epilepsy
Edoardo Ferlazzo,1,2 Emilio Russo,3 Laura Mumoli,1 Chiara Sueri,2 Sara Gasparini,1,2 Caterina Palleria,3 Angelo Labate,1 Antonio Gambardella,1 Giovambattista De Sarro,3 Umberto Aguglia1,2 1Department of Medical and Surgical Sciences, Magna Græcia University, Catanzaro, 2Regional Epilepsy...
Enregistré dans:
Auteurs principaux: | Ferlazzo E, Russo E, Mumoli L, Sueri C, Gasparini S, Palleria C, Labate A, Gambardella A, De Sarro G, Aguglia U |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7c8762e00d1b4a2985a2f631eeb0daef |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Monotherapy for partial epilepsy: focus on levetiracetam
par: Antonio Gambardella, et autres
Publié: (2008) -
Brivaracetam in the treatment of epilepsy: a review of clinical trial data
par: Feyissa AM
Publié: (2019) -
Overnight switch from levetiracetam to brivaracetam. Safety and tolerability
par: L. Abraira, et autres
Publié: (2021) -
Response: Sotos Syndrome and the added value of genetic workup in epilepsy surgery
par: Kenneth A. Myers
Publié: (2021) -
Sotos syndrome and the added value of genetic workup in epilepsy surgery
par: Linda Bättig, et autres
Publié: (2021)